Clinical TrialsSearch results
Number of results: 566
Other
- Randomized clinical trial about the period of antimicrobial prophylaxis administration in hepatocellular carcinoma surgery
- Patients undergoing elective hepatocellular carcinoma surgery
- Randomized clinical trial committee, Japan Society for Surgical Infection
- 2009-12-09
Other
- A phase II trial of TS-1 and weelky CDDP combined with hyperthermia as therapy of advanced and relapsed gastric cancer
- Advanced and relapsed gastric cancer
- Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
- 2009-12-03
Other
- Cohort study evaluating (neo) adjuvant trastuzumab for HER2 positive breast cancer
- Breast cancer
- Japan Breast Cancer Research Group (JBCRG)
- 2009-11-11
Other
- Discover of disease-susceptibility genes of chronic pulmonary aspergillosis
- Chronic pulmonary aspergillosis
- Nagasaki University Graduate School of Biomedical Sciences
- 2009-11-09
Not yet recruiting
- The development of a novel therapy using glycyrrhitinic acid for overactive bladder caused by lower urinary tract obstruction.
- overactive bladder caused by lower urinary tract obstruction
- Urology, Kyoto University
- 2009-11-01
Other
- Effect of middle ear pressure change on clincal symptoms in patients with endolymphatic hydrops of the inner ear
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-10-01
Other
- Human papilloma virus on head and neck squamous cell carcinomas
- Head and neck carcinomas
- Shigeru Hirano
- 2009-10-01
Other
- The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)
- Nonaicoholic fatty liver disease
- Saiseikai Suita Hospital
- 2009-10-01
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10